Authors:
Kane, D
Greaney, T
Shanahan, M
Duffy, G
Bresnihan, B
Gibney, R
FitzGerald, O
Citation: D. Kane et al., The role of ultrasonography in the diagnosis and management of idiopathic plantar fasciitis, RHEUMATOLOG, 40(9), 2001, pp. 1002-1008
Authors:
Cunnane, G
Madigan, A
Murphy, E
Fitzgerald, O
Bresnihan, B
Citation: G. Cunnane et al., The effects of treatment with interleukin-1 receptor antagonist on the inflamed synovial membrane in rheumatoid arthritis (vol 40, pg 62, 2001), RHEUMATOLOG, 40(4), 2001, pp. 482-482
Authors:
Cunnane, G
Madigan, A
Murphy, E
FitzGerald, O
Bresnihan, B
Citation: G. Cunnane et al., The effects of treatment with interleukin-1 receptor antagonist on the inflamed synovial membrane in rheumatoid arthritis, RHEUMATOLOG, 40(1), 2001, pp. 62-69
Citation: B. Bresnihan, The prospect of treating rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist, BIODRUGS, 15(2), 2001, pp. 87-97
Authors:
Doran, M
Wordsworth, P
Bresnihan, B
FitzGerald, O
Citation: M. Doran et al., A distinct syndrome including features of systemic sclerosis, erosive rheumatoid arthritis, anti-topoisomerase antibody, and rheumatoid factor, J RHEUMATOL, 28(4), 2001, pp. 921-922
Citation: B. Bresnihan, The safety and efficacy of interleukin-1 receptor antagonist in the treatment of rheumatoid arthritis, SEM ARTH RH, 30(5), 2001, pp. 17-20
Authors:
Costello, PJ
Winchester, RJ
Curran, SA
Peterson, KS
Kane, DJ
Bresnihan, B
FitzGerald, OM
Citation: Pj. Costello et al., Psoriatic arthritis joint fluids are characterized by CD8 and CD4 T cell clonal expansions that appear antigen driven, J IMMUNOL, 166(4), 2001, pp. 2878-2886
Authors:
Cunnane, G
FitzGerald, O
Hummel, KM
Youssef, PP
Gay, RE
Gay, S
Bresnihan, B
Citation: G. Cunnane et al., Synovial tissue protease gene expression and joint erosions in early rheumatoid arthritis, ARTH RHEUM, 44(8), 2001, pp. 1744-1753
Authors:
McEvoy, AN
Bresnihan, B
FitzGerald, O
Murphy, EP
Citation: An. Mcevoy et al., Corticotropin-releasing hormone signaling in synovial tissue from patientswith early inflammatory arthritis is mediated by the type 1 alpha corticotropin-releasing hormone receptor, ARTH RHEUM, 44(8), 2001, pp. 1761-1767
Authors:
Murphy, EP
McEvoy, A
Conneely, OM
Bresnihan, B
FitzGerald, O
Citation: Ep. Murphy et al., Involvement of the nuclear orphan receptor NURR1 in the regulation of corticotropin-releasing hormone expression and actions in human inflammatory arthritis, ARTH RHEUM, 44(4), 2001, pp. 782-793
Authors:
Cunnane, G
FitzGerald, O
Beeton, C
Cawston, TE
Bresnihan, B
Citation: G. Cunnane et al., Early joint erosions and serum levels of matrix metalloproteinase 1, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 in rheumatoid arthritis, ARTH RHEUM, 44(10), 2001, pp. 2263-2274
Citation: E. Murphy et al., Validated measurement of periarticular bone mineral density at the knee joint by dual energy x ray absorptiometry, ANN RHEUM D, 60(1), 2001, pp. 8-13
Authors:
Jiang, YB
Genant, HK
Watt, I
Cobby, M
Bresnihan, B
Aitchison, R
McCabe, D
Citation: Yb. Jiang et al., A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis - Radiologic progression and correlation of Genant and Larsen scores, ARTH RHEUM, 43(5), 2000, pp. 1001-1009
Authors:
Costello, P
Kane, D
Curran, S
Bresnihan, B
FitzGerald, O
Winchester, R
Citation: P. Costello et al., Psoriatic arthritis - an enthesopathy-based disorder? Comment an the article by McGonagle et al, ARTH RHEUM, 43(3), 2000, pp. 712-713
Citation: Pp. Tak et B. Bresnihan, The pathogenesis and prevention of joint damage in rheumatoid arthritis - Advances from synovial biopsy and tissue analysis, ARTH RHEUM, 43(12), 2000, pp. 2619-2633
Authors:
Bresnihan, B
Tak, PP
Emery, P
Klareskog, L
Breedveld, F
Citation: B. Bresnihan et al., Synovial biopsy in arthritis research: five years of concerted European collaboration, ANN RHEUM D, 59(7), 2000, pp. 506-510
Authors:
Silman, A
Klareskog, L
Breedveld, F
Bresnihan, B
Maini, R
van Riel, P
Symmons, D
Citation: A. Silman et al., Proposal to establish a register for the long term surveillance of adverseevents in patients with rheumatic diseases exposed to biological agents: the EULAR Surveillance Register for Biological Compounds, ANN RHEUM D, 59(6), 2000, pp. 419-420
Citation: Wb. Van Den Berg et B. Bresnihan, Pathogenesis of joint damage in rheumatoid arthritis: evidence of a dominant role for interleukin-I, BEST PR R C, 13(4), 1999, pp. 577-597